Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/23/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
5.21%
CYNOSURE INC CYNO
4.42%
DAWSON GEOPH DWSN
4.33%
MARRIOT VAC VAC
3.27%
BLOOMIN BRAN BLMN
2.93%

Health Management Wins Recognition

by Zacks Equity Research

September 25, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Leading operator of general acute care hospitals, Health Management Associates (HMA - Analyst Report) recently reported that 41 of its facilities have been selected by The Joint Commission as leading performers on critical quality parameters in its latest report on safety and quality of care.

The 41 Health Management facilities (out of 64 Health Management facilities that were considered) were a part of the 620 hospitals selected by The Joint Commission. These institutions constitute the upper 18% of over 3,400 recognized entities providing data for 2011.

Of the 35 Health Management entities which made it to the Top Performers list for 2011, as many as 27 were also on this year’s listing. Three Health Management facilities which made it to this year’s Top Performers list were also on the list in 2011, prior to their becoming a part of the company.
Other than The Joint Commission, Health Management has recently also received accolades from U.S. News & World Report and FORTUNE magazine.

Health Management expects same hospital admissions to decline in the range of 1% to 3% for 2012 whereas, the same hospital adjusted admissions growth is expected to be in the range of -1% to 1%.

For 2012, Health Management maintains its forecast for earnings in the band of 80 cents and 90 cents per share. The forecast excludes about $98 million (or 25 cents per share) of effect from mark-to-market orientation and interest rate swap as well as Medicare and Medicaid HCIT incentive payments in the range of $90 million to $120 million.

Health Management is engaged in the ownership and operation of general acute care hospitals in non-urban communities across the U.S. The company is an active acquirer of underperforming hospitals with a turnaround potential in high-growth markets. Health Management’s competitors, in niche markets include Community Health Systems (CYH - Snapshot Report) and Lifepoint Hospitals (LPNT - Snapshot Report).

Health Management benefits from a gradual growth in admissions largely due to improvement in Emergency Room, sustained physician recruitment and service development. Moreover, it is well placed to expand margins from continuing operations and drive above-industry average earnings growth. While the debt burden remains sizeable, we are somewhat comforted that bad debt is no longer an area of urgent concern.

Health Management, directly or via subsidiaries, operates 10,500 licensed beds in 70 hospitals in rural or semi-urban locations in the U.S.

We currently have a Neutral recommendation on Health Management. The stock currently retains a Zacks #2 Rank, which translates into a short-term “Buy” rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.